Related Articles
Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma
Downregulation of Keap1 contributes to poor prognosis and Axitinib resistance of renal cell carcinoma via upregulation of Nrf2 expression
Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma
Expression of hypoxia-inducible protein 2 in renal cell carcinoma: A promising candidate for molecular targeting therapy
Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis